The human complement receptor type 2 (CR2)/CR1 fusion...

Molecular Immunology 2019 / 01 Vol. 105

The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models

Fridkis-Hareli, Masha, Storek, Michael, Or, Eran, Altman, Richard, Katti, Suresh, Sun, Fang, Peng, Tao, Hunter, Jeff, Johnson, Krista, Wang, Yi, Lundberg, Ante S., Mehta, Gaurav, Banda, Nirmal K., Mic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
105
Language:
english
Journal:
Molecular Immunology
DOI:
10.1016/j.molimm.2018.09.013
Date:
January, 2019
File:
PDF, 3.30 MB
english, 2019
Conversion to is in progress
Conversion to is failed